Inhibition of neuronal (type 1) nitric oxide synthase prevents hyperaemia and hippocampal lesions resulting from kainate-induced seizures

Neuroscience

Volumn 84, Issue 3, 1998, Pages 791-800

  Montecot C ^a   Rondi Reig, L ^a   Springhetti, V ^a   Seylaz, J ^a   Pinard, E ^a  

^a CNRS   (France)

Author keywords

7 nitroindazole; Cerebral blood flow; Kainate; Neuroprotection; Nitric oxide

Indexed keywords

7 NITROINDAZOLE; KAINIC ACID; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; CELL PROTECTION; CONTROLLED STUDY; ENZYME INHIBITION; HIPPOCAMPUS; HYPEREMIA; MALE; NERVE CELL LESION; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; BEHAVIOR, ANIMAL; CEREBROVASCULAR CIRCULATION; ELECTROENCEPHALOGRAPHY; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; HYPEREMIA; KAINIC ACID; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; SEIZURES; STATUS EPILEPTICUS;

EID: 16744367504     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00566-6     Document Type: Article

References (57)

1. Babbedge R. C., Bland-Ward P. A., Hart S. L., Moore P. K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br. J. Pharmac. 110:1993;225-228.
2. Balcioglu A., Maher T. J. Determination of kainic acid-induced release of nitric oxide using a novel hemoglobin trapping technique with microdialysis. J. Neurochem. 61:1993;2311-2313.
3. Beckman J. S., Koppenol W. H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad and the ugly. Am. J. Physiol. 271:1996;C1424-C1437.
4. Ben-Ari Y., Tremblay E., Riche D., Ghilini G., Naquet R. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience. 6:1981;1361-1391.
5. Bindokas V. P., Jordan J., Lee C. C., Miller R. J. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J. Neurosci. 16:1996;1324-1336.
6. Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. natn. Acad. Sci. U.S.A. 86:1989;9030-9033.
7. Bruce A. J., Baudry M. Oxygen free radicals in rat limbic structures after kainate-induced seizures. Free. Radicals Biol. Med. 18:1995;993-1002.
8. Cholet N., Bonvento G., Seylaz J. Effect of neuronal NO synthase inhibition on the cerebral vasodilatory response to somatosensory stimulation. Brain Res. 708:1996;197-200.
9. Cholet N., Seylaz J., Lacombe P., Bonvento G. Neuronal NO synthase inhibition induces cortical uncoupling between cerebrovascular and metabolic responses to somatosensory activation. J. cerebr. Blood Flow Metab. 17:1997;S602.
10. Clavier N., Tobin J., Kirsch J. R., Izuta M., Traystman R. J. Brain nitric oxide synthase activity in normal, hypertensive, and stroke prone rats. Stroke. 25:1994;1674-1678.
11. Connop B. P., Rolfe N. G., Boegman R. J., Jhamandas K., Beninger R. J. Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole. Neuropharmacology. 33:1994;1439-1445.
12. Dawson V. L., Dawson T. M., London E. D., Bredt D. S. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. natn. Acad. Sci. U.S.A. 88:1991;6368-6371.
13. Dawson V. L., Kizushi V. M., Huang P. L., Snyder S. H., Dawson T. M. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16:1996;2479-2487.
14. Di Monte D. A., Royland J. E., Jakowec M. W., Langston J. W. Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J. Neurochem. 67:1996;2443-2450.
15. Dinerman J. L., Dawson T. M., Schell M. J., Snowman A., Snyder S. H. Endothelial nitric oxide localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc. natn. Acad. Sci. U.S.A. 91:1994;4214-4218.
16. East S. J., Garthwaite J. NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway. Neurosci. Lett. 123:1991;17-19.
17. 1 hippocampal neurons and other central nervous system neurons. Neuroscience. 63:1994;679-689.
18. Faraci F. M., Brian J. E. 7-Nitroindazole inhibits brain nitric oxide synthase and cerebral vasodilatation to N-methyl-D-aspartate. Stroke. 26:1995;2172-2176.
19. Garthwaite G., Garthwaite J. Nitric oxide does not mediate acute glutamate neurotoxicity, nor is it neuroprotective, in rat brain slices. Neuropharmacology. 33:1994;1431-1438.
20. Garthwaite J., Southam E., Anderton M. A kainate receptor linked to nitric oxide synthesis from arginine. J. Neurochem. 53:1989;1952-1954.
21. Halliwell B. and Gutteridge J. M. C. (1989) Free Radicals in Biology and Medicine, 2nd edn. Clarendon, Oxford.
22. Huie R. E., Padmaja S. The reaction of NO with superoxide. Free Radical Res. Commun. 18:1993;195-199.
23. Iadecola C., Pelligrino D. A., Moskowitz M. A., Lassen N. A. Nitric oxide synthase inhibition and cerebrovascular regulation. J. cerebr. Blood Flow Metab. 14:1994;175-192.
24. Iadecola C., Yang G., Xu S. 7-Nitroindazole attenuates vasodilation from cerebellar parallel fiber stimulation but not acetylcholine. Am. J. Physiol. 270:1996;R914-R919.
25. Itzhak Y., Ali S. F. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J. Neurochem. 67:1996;1770-1773.
26. 1 region of rat hippocampal slices. Neurosci. Lett. 210:1996;157-160.
27. Kalisch B. E., Connop B. P., Jhamandas K., Beninger R. J., Boegman R. J. Differential action of 7-nitro indazole on rat brain nitric oxide synthase. Neurosci. Lett. 219:1996;75-78.
28. Kelly P. A. T., Ritchie I. M., Arbuthnott G. W. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole: effects upon local cerebral blood flow and glucose use in the rat. J. cerebr. Blood Flow Metab. 15:1995;766-773.
29. Lafon-Cazal M., Culcasi M., Gaven F., Pietri S., Bockaert J. Nitric oxide, superoxide and peroxynitrite: putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology. 32:1993;1259-1266.
30. Löschmann P. A., Eblen F., Wüllner U., Klockgether T. NMDA-mediated toxicity to striatal neurons is not reversed by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J. neural Transm. 46:1995;87-95.
31. Lothmann E. W., Collins R. C. Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 218:1981;299-318.
32. Mackenzie G. M., Rose S., Bland-Ward P. A., Moore P. K., Jenner P., Marsden C. D. Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. NeuroReport. 5:1994;1993-1996.
33. Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: physiology, pathology, and pharmacology. Pharmac. Rev. 43:1991;109-142.
34. Montécot C., Borredon J., Seylaz J., Pinard E. Nitric oxide of neuronal origin is involved in cerebral blood flow increase during seizures induced by kainate. J. cerebr. Blood Flow Metab. 17:1997;94-99.
35. Moore P. K. and Bland-Ward P. A. (1996) 7-Nitroindazole: an inhibitor of nitric oxide synthase. In Methods in Enzymology (eds Abelson J. N. and Simon M. I.), Vol. 268, pp. 393-398. Academic, San Diego.
36. Mülsch A., Busse R., Mordvintcev P. I., Vanin A. F., Nielsen E. O., Scheel-Krüger J., Olesen S. P. Nitric oxide promotes seizure activity in kainate-treated rats. NeuroReport. 5:1994;2325-2328.
37. O'Neill M. J., Hicks C., Ward M. Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia. Eur. J. Pharmac. 310:1996;115-122.
38. Panahian N., Yoshida T., Huang P. L., Heddley-Whyte E. T., Dalkara T., Fishman M. C., Moskowitz M. A. Attenuated hippocampal damage after global cerebral ischemia in mice mutant in neuronal nitric oxide synthase. Neuroscience. 72:1996;343-354.
39. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic, Sydney.
40. Pinard E., Rigaud A. S., Riche D., Naquet R., Seylaz J. Continuous determination of the cerebrovascular changes induced by bicuculline and kainic acid in unanaesthetized spontaneously breathing rats. Neuroscience. 23:1987;943-952.
41. 3 region of the hippocampus during kainate-induced seizures. Neuroscience. 13:1984;1039-1049.
42. Rigaud-Monnet A. S., Pinard E., Borredon J., Seylaz J. Blockade of NO synthesis inhibits hippocampal hyperemia in kainic acid-induced seizures. J. cerebr. Blood Flow Metab. 14:1994;581-590.
43. Schottler F., Collins J. L., Fergus A., Okonkwo D., Kassel N. F., Lee K. S. Structural interactions between NOS-positive neurons and blood vessels in the hippocampus. NeuroReport. 7:1996;966-968.
44. Schulz J. B., Henshaw D. R., Siwek D., Jenkins B. G., Ferrante R. J., Cipolloni P. B., Kowall N. W., Rosen B. R., Beal M. F. Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64:1995;2239-2247.
45. Schulz J. B., Matthews R. T., Jenkins B. G., Ferrante R. J., Siwek D., Henshaw D. R., Cipolloni P. B., Mecocci P., Kowall N. W., Rosen B. R., Beal M. F. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15:1995;8419-8429.
46. Seylaz J., Pinard E. Continuous measurement of gas partial pressures in intracerebral tissue. J. appl. Physiol.: Respir. Environ. Exercise Physiol. 44:1978;528-533.
47. 2, and blood flow measurements by mass spectrometry. Am. J. Physiol. 245:1983;H513-H518.
48. Siesjö B. K. Cell damage in the brain: a speculative synthesis. J. cerebr. Blood Flow Metab. 1:1981;155-185.
49. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42:1994;1-32.
50. Sun A. Y., Cheng Y., Bu Q., Olfield F. The biochemical mechanisms of the excitotoxicity of kainic acid. Molec. chem. Neuropath. 17:1992;51-63.
51. Ueda Y., Yokoyama H., Niwa R., Konaka R., Ohya-Nishiguchi H., Kamada H. Generation of lipid radicals in the hippocampal extracellular space during kainic acid-induced seizures in rats. Epilepsy Res. 26:1997;329-333.
52. Valtschanoff J. G., Weinberg R. J., Kharazia V. N., Nakane M., Schmidt H. H. H. W. Neurons in rat hippocampus that synthesize nitric oxide. J. comp. Neurol. 331:1993;111-121.
53. Vincent S. R., Hope B. T. Neurons that say NO. Trends Neurosci. 15:1992;108-113.
54. Wang Q., Pelligrino D. A., Baughman V. L., Koenig H. M., Albrecht R. F. The role of neuronal nitric oxide synthase in regulation of cerebral blood flow in normocapnia and hypercapnia in rats. J. cerebr. Blood Flow Metab. 15:1995;774-778.
55. Wendland B., Schweizer F. E., Ryan T. A., Nakane M., Murad F., Scheller R. H., Tsien R. W. Existence of nitric oxide synthase in rat hippocampal pyramidal cells. Proc. natn. Acad. Sci. U.S.A. 91:1994;2151-2155.
56. Yoshida T., Limmroth V., Irikura K., Moskowitz M. A. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J. cerebr. Blood Flow Metab. 14:1994;924-929.
57. Zhang Y., Samson F. E., Nelson S. R., Pazdernik T. L. Nitric oxide detection with intracerebral microdialysis: important considerations in the application of the hemoglobin-trapping technique. J. Neurosci. Meth. 68:1996;165-173.